SBIR/STTR Research Award

Tunable Electronic Brachytherapy System

Award identifier b34e4c17d975c7912699f2d2cee502c2262e2d9afa9011dda9edf46a1968dbacAwarding agency Department of Energy

Award amount

$199,597

Program and phase

SBIR · Phase I

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Energy
Branch
Not reported
Recipient company
RADIABEAM SYSTEMS, LLC
Proposal award date
2021-06-28
Contract end date
2022-03-27
UEI
GRKLZTXQZXE6
Solicitation number
Not reported
Topic code
02c

Research abstract

Brachytherapy, a crucial form of radiation therapy for cancer treatment, utilizes small radioactive sources. It is a cost-effective approach, with advantages in implementation in terms of dosimetry. However, the persistent long-term radioactivity of sources creates numerous safety and security issues and associated costs to manage such issues. Also, the lack of energy tunability and directionality restrict the potential efficacy. This project will develop an innovative system for delivery of energetic electron beams for brachytherapy to robustly replace the capabilities of currently employed radiation sources. The approach relies on electron beam transport in current-carrying plasma channels, which will be adapted to allow implementation using existing high dose rate (HDR) applicators. The electron source itself is to be obtained from an existing technical approach: a compact linear accelerator (linac). This path to brachytherapy yields a directional, tunable radioactive source-free solution. In Phase I, the design of the electronic brachytherapy system will be completed with simulations to model and optimize the plasma channel, verify the electron beam dynamics, and design the Xray converter. Preliminary considerations of treatment planning with the device will be explored. Finally, the prototype fabrication and testing to be carried out in Phase II will be planned. Cancer is a global problem, accounting for almost 13% of all deaths worldwide and is one of the fastest growing diseases on earth. The market for brachytherapy devices is more than $600 million, yet is a small portion of the total $6.7 billion market for radiation therapy equipment due to the complications of using radioisotopes. The flexible, tunable electronic source of brachytherapy developed in this project will enable rapid growth of this market segment and offer a new tool for treating cancer.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

61 SBIR/STTR records share this UEI (2013–2025). Reported award amounts total $34,857,770. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Energy

Agency intelligence

Department of Energy

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.